Details of the Drug Formulaction | DrugMAP

General Information of Drug Formulation (ID: F13600)

Formulation Name

Methylphenidate 30 mg capsule

Company

Actavis Pharma; Actavis South Atlantic

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Methylphenidate	DM7SJD6	Attention deficit hyperactivity disorder	6A05.Z	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Acetone	E00004	180	Solvent
Acetyltributyl citrate	E00127	6505	Plasticizing agent
D&C red no. 28	E00491	6097185	Colorant
FD&C blue no. 1	E00263	19700	Colorant
Ferrosoferric oxide	E00231	14789	Colorant
Potassium hydroxide	E00233	14797	Alkalizing agent
Saccharose	E00091	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent
Talc	E00520	16211421	Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide	E00322	26042	Coating agent; Colorant; Opacifying agent
Water	E00035	962	Solvent

--------------------